Announcements

8 April 2025
Gout, Urate, and Crystal Deposition Disease Accepted for Coverage in Scopus


We are pleased to announce that Gout, Urate, and Crystal Deposition Disease (GUCDD, ISSN: 2813-4583) has been selected for coverage in the Scopus indexing database in April 2025. We would like to extend our sincerest gratitude to all of the authors, reviewers, and editors who have contributed to this journal and helped us accomplish this achievement.

GUCDD is an international, open access, peer-review journal on gout, urate, and crystal deposition disease. Gout and crystal deposition-associated disorders are among the leading causes of inflammation and arthritis around the world, with gout being the most common form of inflammatory arthritis affecting adults.

Moving forward, readers and authors will be particularly interested in epidemiology, pathophysiology, imaging, diagnosis, treatment, and outcomes of gout, hyperuricemia, and degenerative and inflammatory calcium crystal arthropathies (including calcium pyrophosphate and basic calcium phosphate crystal deposition disease). Major sources of published works will include clinicians such as rheumatologists, nephrologists, cardiologists, endocrinologists, and orthopedists, and researchers in epidemiology, genomics, bioinformatics, various data sciences, and advanced imaging.

To make the most of the opportunity afforded by this coverage, we would like to invite you to submit your research to GUCDD. If you are working on a paper concerning any topic within the scope of the journal, please submit it via the journal’s website: https://www.mdpi.com/journal/gucdd.

GUCDD Editorial Office

More News...
Back to TopTop